Enliven Therapeutics ELVN
NASDAQ ELVN
$46.97 +0.76 (+1.64%)
At close: Oct 2, 2026 · 4:00 PM EDT

Enliven Therapeutics (ELVN) Depreciation and Depletion (2019 - 2026)

Updated

Enliven Therapeutics' Depreciation and Depletion came in at $7,000 for Q2 2026, down 91.4% from $81,000 a year earlier and down 50.0% from the prior quarter.

Analysis

Enliven Therapeutics (ELVN) Depreciation and Depletion (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Enliven Therapeutics reported Depreciation and Depletion of $129,000, down 59.0% year-over-year; for FY2025, it came in at $263,000, down 17.0% from FY2024.

  • Depreciation and Depletion carries a five-year compound annual growth rate of 21.3% (FY2020 to FY2025).
  • Going back by year, Depreciation and Depletion was $317,000 in FY2024 (+6.7%), $297,000 in FY2023 (+38.1%), $215,000 in FY2022 (+115.0%) and $100,000 in FY2021 (unchanged).
  • The Q2 2026 figure represents the lowest quarterly Depreciation and Depletion in data going back to Q4 2019.
  • Year-over-year, Depreciation and Depletion has declined for four consecutive quarters, with an average decline of 29.3% over the last eight quarters.
  • The fastest year-over-year change in Depreciation and Depletion over five years came in Q3 2022 (growth of 150.0%), and the weakest in Q2 2026 (a decline of 91.4%).
  • Business Quant data shows ELVN's Depreciation and Depletion at $14,000 (Q1 2026), $46,000 (Q4 2025) and $62,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Enliven Therapeutics 3.44 Bn 3.44 Bn - 7,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7,000.00
Mar 31, 2026 14,000.00
Dec 31, 2025 46,000.00
Sep 30, 2025 62,000.00
Jun 30, 2025 81,000.00
Mar 31, 2025 74,000.00
Dec 31, 2024 80,000.00
Sep 30, 2024 80,000.00
Jun 30, 2024 78,000.00
Mar 31, 2024 79,000.00
Dec 31, 2023 78,000.00
Sep 30, 2023 78,000.00
Jun 30, 2023 74,000.00
Mar 31, 2023 67,000.00
Dec 31, 2022 64,000.00
Sep 30, 2022 60,000.00
Jun 30, 2022 52,000.00
Mar 31, 2022 39,000.00
Dec 31, 2021 26,000.00
Sep 30, 2021 24,000.00
API Access

Enliven Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ELVN&period=max&api_key=YOUR_API_KEY